Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Status Active, not recruiting

Clinical Trial Summary

This study is being conducted to determine if Whole Body MRI (WBMRI) can be used to identify Atypical Neurofibromas (ANF) in Neurofibromatosis Type 1 (NF1) patients with high tumor burden. Each enrolled participant will have two (2) WBMRIs without sedation during the study period. Eligible participants must be Male or Female between the ages of 8-30 with diagnosed NF1; with one or more PN greater than 3cm in diameter and willing to comply with study procedures.

Clinical Trial Description

This is a study to determine the feasibility of using Whole Body MRI (WBMRI) to detect Atypical Plexiform Neurofibromas (ANF) among Neurofibromatosis Type 1 (NF1) patients who are at highest risk for developing these tumors. In order to do this, the investigators will prospectively obtain WBMRI scans on patients with high plexiform tumor burden (which investigators will define as >=1 plexiform neurofibroma (PN) that is >3cm in diameter on MRI) at the same time as their regularly scheduled MRI to allow for radiographic comparison of the identified PNs. In this study, the investigators will plan to establish a method that effectively characterizes PNs in terms of their volume, radiographic appearance on WBMRI and association with clinical characteristics. As an exploratory aim, the investigators plan to collect blood samples from each patient at the same time as the MRI to determine the feasibility of isolating cfDNA (circulating free DNA) from plasma of patients with high plexiform tumor burden. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03820778
Study type	Interventional
Source	Children's National Research Institute
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 12, 2018
Completion date	August 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01362803` - AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors	Phase 1/Phase 2
Completed	`NCT00352599` - Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)	Phase 1
Completed	`NCT05005845` - NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)	Phase 2
Completed	`NCT03531814` - Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials	N/A
Completed	`NCT00846430` - Medical Treatment of "High-Risk" Neurofibromas	Phase 2
Completed	`NCT03433183` - SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors	Phase 2
Recruiting	`NCT05331105` - HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas	Phase 2
Completed	`NCT03310996` - Non-invasive Stimulation in Neurofibromatosis Type 1	N/A
Recruiting	`NCT03406208` - Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing	N/A
Not yet recruiting	`NCT05849662` - A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia	Phase 1/Phase 2
Recruiting	`NCT04750928` - Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas	Phase 1/Phase 2
Not yet recruiting	`NCT06262113` - A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1	N/A
Active, not recruiting	`NCT04924608` - Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas	Phase 3
Recruiting	`NCT02544022` - Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
Recruiting	`NCT04941027` - Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
Completed	`NCT02153931` - Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
Completed	`NCT05196854` - Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1	N/A
Active, not recruiting	`NCT01650142` - Modifying Genes in Neurofibromatosis 1	N/A
Completed	`NCT05377008` - Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1	N/A
Completed	`NCT04879160` - Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial